Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Surgical Research|June 19, 2007
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infectionsRoberto Ghiselli, Oscar Cirioni, Andrea Giacometti, et al.
Cancers|March 29, 2023
T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative ReviewGerardo Cazzato, Eliano Cascardi, Anna Colagrande, et al.
Cancers|December 30, 2025
Clinicopathological Significance of Pluripotent Factors in Sinonasal Intestinal-Type AdenocarcinomaFederica Monaco, Alberto Vallieri, Luca Volpini, et al.
European Journal of Haematology|July 8, 2005
Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoidesSerena Rupoli, Gaia Goteri, Stefano Pulini, et al.
BMC Cancer|December 8, 2014
Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferationMaria Beatrice Morelli, Consuelo Amantini, Massimo Nabissi, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic ApproachMagda Zanelli, Andrea Palicelli, Francesca Sanguedolce, et al.
Human Pathology|March 30, 2023
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomasSilvia Uccella, Gaia Goteri, Antonino Maiorana, et al.
Oncology and Therapy|February 4, 2025
The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in ItalyVeronica Agostinelli, Giada Torresi, Valentina Tarantino, et al.
International Journal of Cancer|November 4, 2025
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)Javier Molina-Cerrillo, Giandomenico Roviello, Maria T Bourlon, et al.
JCO Global Oncology|October 29, 2025
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 StudyFrancesco Massari, Matteo Rosellini, Bohuslav Melichar, et al.
Pageof 7